Opportunity Information: Apply for PAR 22 221
This funding opportunity, titled "AD/ADRD, Adverse Childhood Experiences, and Social Determinants of Health Ancillary Studies of Existing Longitudinal Cohorts (R01 - Clinical Trial Not Allowed)" (PAR-22-221), is a National Institutes of Health (NIH) discretionary grant program designed to support research that makes deeper and more creative use of data that already exist in Alzheimer’s disease and Alzheimer’s disease-related dementias (AD/ADRD) longitudinal cohort resources. The main idea is to fund ancillary studies that build on these established cohorts rather than starting entirely new cohort studies or running clinical trials. Projects are expected to use existing datasets, repositories, and cohort infrastructures to generate new insights into how early-life conditions shape brain health and dementia risk later in life.
The scientific focus centers on understanding how adverse childhood experiences (ACEs) and early-life social determinants of health (SDOH) connect to AD/ADRD outcomes across the lifespan. This includes studying links between childhood adversity or social disadvantage and later development of cognitive impairment and dementia, and specifically how those early exposures may be reflected in, or interact with, AD/ADRD biomarkers. In practical terms, the FOA encourages work that connects early-life environments and experiences (such as socioeconomic conditions, education-related factors, neighborhood context, structural inequities, household instability, trauma, abuse, neglect, or chronic early stressors) to biological and clinical indicators relevant to dementia. Biomarkers may include established or emerging measures used in AD/ADRD research, such as neuroimaging markers, blood- or CSF-based markers, genetics and genomics, and other biological signals that help characterize disease risk, onset, or progression.
A major emphasis is on populations that experience health disparities. The FOA highlights the importance of improving understanding of dementia risk and trajectories in groups that have historically been underrepresented in research or disproportionately affected by inequities in healthcare access, education, income, environmental exposures, discrimination, and other structural drivers of health. Applications that directly address these disparities, improve measurement of SDOH and ACEs in cohorts, or conduct analyses that clarify mechanisms behind inequitable outcomes align strongly with the purpose of the announcement.
The award mechanism is an NIH R01 research project grant, and the FOA clearly states "Clinical Trial Not Allowed," meaning the supported work should not involve prospective assignment of human participants to interventions to evaluate health-related outcomes in a clinical trial framework. Instead, projects are expected to be observational, analytical, or focused on expanding and leveraging existing longitudinal cohort resources. The overall goal is to accelerate discovery by using data already collected (or data that can be feasibly added as ancillary components) to answer new questions about life-course pathways to cognitive decline and dementia, including biological embedding of early adversity and social conditions.
Eligibility is broad and includes many types of organizations. Eligible applicants include state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations that are not federally recognized; public and Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses) and small businesses; and other entities. The FOA also explicitly calls out additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, non-domestic (non-U.S.) entities (foreign organizations), and U.S. territories or possessions. This wide eligibility scope is consistent with the FOA’s interest in broad participation and in supporting research that can address disparities and community-relevant questions using established cohort resources.
Administratively, the opportunity is listed under NIH with CFDA numbers 93.853 and 93.866, uses the grant funding instrument, and falls under the health funding activity category. The original closing date shown in the source data is 2022-10-05, and the posting (creation) date is 2022-08-10. The source excerpt does not specify an award ceiling or expected number of awards, so those details are not provided here. Overall, the program is best understood as a targeted push to connect early-life adversity and social context with dementia biology and clinical outcomes by maximizing the scientific yield of existing longitudinal AD/ADRD cohort data, with a deliberate focus on improving knowledge relevant to groups facing longstanding inequities in health and healthcare.Apply for PAR 22 221
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "AD/ADRD, Adverse Childhood Experiences, and Social Determinants of Health Ancillary Studies of Existing Longitudinal Cohorts (R01 - Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.853, 93.866.
- This funding opportunity was created on 2022-08-10.
- Applicants must submit their applications by 2022-10-05. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: FY2023 ABPP - Battlefield Land Acquisition Grant
Previous opportunity: Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 22 221
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 22 221) also looked into and applied for these:
| Funding Opportunity |
|---|
| Javits Neuroscience Investigator Award Extension Request (Type 4 Clinical Trial Optional) Apply for PAR 23 022 Funding Number: PAR 23 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional) Apply for PAR 22 228 Funding Number: PAR 22 228 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Fostering Mental, Emotional, and Behavioral (MEB) Health Among Children in School Settings: Opportunities for Multisite Trials of Complementary and Integrative Health Interventions (Clinical Trial Optional) Apply for RFA AT 23 003 Funding Number: RFA AT 23 003 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Research Resource Center to Build an Open-Access Repository and Database for Anatomical and Physiological Correlates of Acupoints (U24, Clinical Trial Optional) Apply for RFA AT 23 005 Funding Number: RFA AT 23 005 Agency: National Institutes of Health Category: Health Funding Amount: $700,000 |
| FY 2023 AmeriCorps State and National Public Health AmeriCorps Grants Apply for AC 08 20 22 Funding Number: AC 08 20 22 Agency: AmeriCorps Category: Health Funding Amount: Case Dependent |
| Practice-Based Research Integrating Multidisciplinary Experiences in Dental Schools (PRIMED) (U01 Clinical Trial Not Allowed) Apply for RFA DE 23 012 Funding Number: RFA DE 23 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AHRQ Conference Grant Programs (R13) Apply for PA 22 238 Funding Number: PA 22 238 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $50,000 |
| Maintaining Immunity after Immunization (U01 Clinical Trial Not Allowed) Apply for RFA AI 22 055 Funding Number: RFA AI 22 055 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| REsearch Across Complementary and Integrative Health Institutions (REACH) Virtual Resource Centers (U24 Clinical Trial Not Allowed) Apply for RFA AT 23 007 Funding Number: RFA AT 23 007 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Optimization of Genome Editing Therapeutics for Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) (U01 - Clinical Trials Not Allowed) Apply for RFA NS 23 017 Funding Number: RFA NS 23 017 Agency: National Institutes of Health Category: Health Funding Amount: $650,000 |
| NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Independent Clinical Trial Not Allowed) Apply for PAR 22 226 Funding Number: PAR 22 226 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed) Apply for PAR 22 227 Funding Number: PAR 22 227 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Blood Brain Barrier Response to Antibodies Targeting Beta-Amyloid (R01 - Clinical Trial Not Allowed) Apply for PAR 22 235 Funding Number: PAR 22 235 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed) Apply for PAR 23 027 Funding Number: PAR 23 027 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AHRQ National Research Service Award (NRSA) Institutional Research Training Grant (T32) Apply for RFA HS 22 010 Funding Number: RFA HS 22 010 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Understanding the Supply of Professional Dementia Care Providers and Their Decisions (U54 Clinical Trial Not Allowed) Apply for RFA AG 23 018 Funding Number: RFA AG 23 018 Agency: National Institutes of Health Category: Health Funding Amount: $16,200,000 |
| Development of Animal Models and Related Materials for HIV/AIDS Research (R24 Clinical Trials Not Allowed) Apply for PAR 22 204 Funding Number: PAR 22 204 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Resource-Related Research Projects for Development of Animal Models and Related Materials (R24 Clinical Trials Not-Allowed) Apply for RFA OD 22 013 Funding Number: RFA OD 22 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) Apply for PAR 22 225 Funding Number: PAR 22 225 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional) Apply for PAR 22 250 Funding Number: PAR 22 250 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 22 221", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.